Li Y, Chen S, Liu Y, Liu P, Li S, Liu N
Fish Physiol Biochem. 2024; 50(6):2373-2388.
PMID: 39150597
DOI: 10.1007/s10695-024-01379-6.
Kim C, Lee J, Park S
Front Endocrinol (Lausanne). 2024; 14:1152579.
PMID: 38317714
PMC: 10839044.
DOI: 10.3389/fendo.2023.1152579.
Fatimawali , Tallei T, Johnson Kepel B, Bodhi W, Manampiring A, Nainu F
Medicina (Kaunas). 2023; 59(11).
PMID: 38003949
PMC: 10673377.
DOI: 10.3390/medicina59111899.
Tsay A, Wang J
Int J Mol Sci. 2023; 24(16).
PMID: 37628845
PMC: 10454413.
DOI: 10.3390/ijms241612665.
Uehara K, Santoleri D, Garcia Whitlock A, Titchenell P
Compr Physiol. 2023; 13(3):4785-4809.
PMID: 37358513
PMC: 10760932.
DOI: 10.1002/cphy.c220015.
Extracellular Calcium-Induced Calcium Transient Regulating the Proliferation of Osteoblasts through Glycolysis Metabolism Pathways.
Gao X, Di X, Li J, Kang Y, Xie W, Sun L
Int J Mol Sci. 2023; 24(5).
PMID: 36902420
PMC: 10003245.
DOI: 10.3390/ijms24054991.
Circulating microRNA levels differ in the early stages of insulin resistance in prepubertal children with obesity.
Santos D, Porter-Gill P, Goode G, Delhey L, Sorensen A, Rose S
Life Sci. 2022; 312:121246.
PMID: 36455651
PMC: 10375861.
DOI: 10.1016/j.lfs.2022.121246.
Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.
Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z
Acta Pharm Sin B. 2022; 12(6):2887-2904.
PMID: 35755276
PMC: 9214054.
DOI: 10.1016/j.apsb.2021.12.023.
Differential effects of single fatty acids and fatty acid mixtures on the phosphoinositide 3-kinase/Akt/eNOS pathway in endothelial cells.
Jackson K, Newens K, Fry M, Thompson A, Williams C
Eur J Nutr. 2022; 61(5):2463-2473.
PMID: 35157107
PMC: 9279250.
DOI: 10.1007/s00394-022-02821-2.
Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.
Wang Z
Cells. 2021; 10(12).
PMID: 34943835
PMC: 8699227.
DOI: 10.3390/cells10123327.
The regulatory subunits of PI3K, p85α and p85β, differentially affect BRD7-mediated regulation of insulin signaling.
Lee J, Liu R, Park S
J Mol Cell Biol. 2021; 13(12):889-901.
PMID: 34751372
PMC: 8800525.
DOI: 10.1093/jmcb/mjab073.
Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis.
Mukherjee R, Vanaja K, Boyer J, Gadal S, Solomon H, Chandarlapaty S
Mol Cell. 2021; 81(4):708-723.e5.
PMID: 33606974
PMC: 8384339.
DOI: 10.1016/j.molcel.2021.01.033.
Metformin: Possible Use of a Diabetes Drug in Treatment of Cancer.
Vacheron A, Wynn A, Zuber J, Solomon S
Clin Res Diabetes Endocrinol. 2021; 1(1).
PMID: 33385166
PMC: 7773208.
Emerging Roles of BRD7 in Pathophysiology.
Park S, Lee J
Int J Mol Sci. 2020; 21(19).
PMID: 32992509
PMC: 7583729.
DOI: 10.3390/ijms21197127.
Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG).
Myronovych A, Bhattacharjee J, Salazar-Gonzalez R, Tan B, Mowery S, Ferguson D
Am J Physiol Gastrointest Liver Physiol. 2020; .
PMID: 32967428
PMC: 7792670.
DOI: 10.1152/ajpgi.00175.2020.
Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
Mendenhall M, Liu S, Portley M, OMard D, Fattah R, Szabo R
Nat Microbiol. 2020; 5(12):1464-1471.
PMID: 32895527
PMC: 11540063.
DOI: 10.1038/s41564-020-0782-1.
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan M, Ghosh A, Variya B, Santharam M, Ihsan A, Ramanathan S
BMC Cancer. 2020; 20(1):774.
PMID: 32807134
PMC: 7433106.
DOI: 10.1186/s12885-020-07285-3.
Class IA PI3K regulatory subunits: p110-independent roles and structures.
Fox M, Mott H, Owen D
Biochem Soc Trans. 2020; 48(4):1397-1417.
PMID: 32677674
PMC: 7458397.
DOI: 10.1042/BST20190845.
Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight.
Sharma J, Bhardwaj V, Purohit R
ACS Omega. 2019; 4(14):15815-15823.
PMID: 31592171
PMC: 6776984.
DOI: 10.1021/acsomega.9b01439.
Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.
Wynn A, Vacheron A, Zuber J, Solomon S
Am J Med Sci. 2019; 358(3):200-203.
PMID: 31324361
PMC: 6708761.
DOI: 10.1016/j.amjms.2019.06.002.